Actively Recruiting
Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
Led by Nanchong Central Hospital · Updated on 2025-05-21
160
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy
CONDITIONS
Official Title
Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed adenocarcinoma of the stomach, stages T1 to T4
- Eastern Cooperative Oncology Group performance status of 0 or 1
- Adequate organ function
You will not qualify if you...
- Presence of distant metastasis
- Esophageal invasion longer than 3 cm
- Borrmann type 4 or large (more than 8 cm) type 3 carcinoma
- Previous chemotherapy or radiation therapy for any other cancers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yunhong Tian
Nanchong, Sichuan, China, 637000
Actively Recruiting
Research Team
Y
Yunhong Tian, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here